Brian E Bunnell1, Gina Sprague2, Suparna Qanungo3, Michelle Nichols3, Kathryn Magruder4,5, Steven Lauzon5, Jihad S Obeid1, Leslie A Lenert1, Brandon M Welch1. 1. Department of Psychiatry and Behavioral Sciences, Biomedical Informatics Center, College of Medicine, Medical University of South Carolina, Charleston, South Carolina. 2. Doxy.me, LLC, Rochester, New York. 3. Department of Nursing, College of Nursing, Medical University of South Carolina, Charleston, South Carolina. 4. Department of Psychiatry and College of Medicine, Medical University of South Carolina, Charleston, South Carolina. 5. Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Abstract
Background: Clinical trials are key to ensuring high-quality, effective, and safe health care interventions, but there are many barriers to their successful and timely implementation. Difficulties with participant recruitment and enrollment are largely affected by difficulties with obtaining informed consent. Teleconsent is a telemedicine- based approach to obtaining informed consent and offers a unique solution to limitations of traditional consent approaches. Methods: We conducted a survey among 134 clinical trial researchers in academic/university-, industry-, and clinically based settings. The survey addressed important aspects of teleconsent, potential teleconsent enhancements, and other telehealth capabilities to support clinical research. Results: The majority of respondents viewed teleconsent as an important approach for obtaining informed consent and indicated that they would likely use teleconsent if available. Consenting participants at remote sites, increasing access to clinical trials, and consenting participants in their homes were viewed as the greatest opportunities for teleconsent. Features for building, validating, and assessing understanding of teleconsent forms, mobile capabilities, three-way teleconsent calls, and direct links to forms via recruitment websites were viewed as important teleconsent enhancements. Other telehealth capabilities to support clinical research, including surveys, file transfer, three-way video, screenshare, and photo capture during telemedicine visits, and proposed telemedicine capabilities such as video call recording, ID information capture, and integration of medical devices, were also viewed as important. Conclusions: Teleconsent and telemedicine are promising solutions to some common challenges to clinical trials. Many barriers to study recruitment and enrollment might be overcome by investing time and resources and further evaluating this technology.
Background: Clinical trials are key to ensuring high-quality, effective, and safe health care interventions, but there are many barriers to their successful and timely implementation. Difficulties with participant recruitment and enrollment are largely affected by difficulties with obtaining informed consent. Teleconsent is a telemedicine- based approach to obtaining informed consent and offers a unique solution to limitations of traditional consent approaches. Methods: We conducted a survey among 134 clinical trial researchers in academic/university-, industry-, and clinically based settings. The survey addressed important aspects of teleconsent, potential teleconsent enhancements, and other telehealth capabilities to support clinical research. Results: The majority of respondents viewed teleconsent as an important approach for obtaining informed consent and indicated that they would likely use teleconsent if available. Consenting participants at remote sites, increasing access to clinical trials, and consenting participants in their homes were viewed as the greatest opportunities for teleconsent. Features for building, validating, and assessing understanding of teleconsent forms, mobile capabilities, three-way teleconsent calls, and direct links to forms via recruitment websites were viewed as important teleconsent enhancements. Other telehealth capabilities to support clinical research, including surveys, file transfer, three-way video, screenshare, and photo capture during telemedicine visits, and proposed telemedicine capabilities such as video call recording, ID information capture, and integration of medical devices, were also viewed as important. Conclusions: Teleconsent and telemedicine are promising solutions to some common challenges to clinical trials. Many barriers to study recruitment and enrollment might be overcome by investing time and resources and further evaluating this technology.
Authors: Nancy S Sung; William F Crowley; Myron Genel; Patricia Salber; Lewis Sandy; Louis M Sherwood; Stephen B Johnson; Veronica Catanese; Hugh Tilson; Kenneth Getz; Elaine L Larson; David Scheinberg; E Albert Reece; Harold Slavkin; Adrian Dobs; Jack Grebb; Rick A Martinez; Allan Korn; David Rimoin Journal: JAMA Date: 2003-03-12 Impact factor: 56.272
Authors: Sarah B Mulkey; Margarita Arroyave-Wessel; Colleen Peyton; Emily Ansusinha; Corina Gutierrez; Andrea Sorkar; Andres Cure; Yhina Samper; Daniela Cure; Michael E Msall; Carlos Cure Journal: J Telemed Telecare Date: 2021-12-28 Impact factor: 6.344
Authors: Francesco Gavazzi; Laura Adang; Amy Waldman; Amanda K Jan; Geraldine Liu; Scott A Lorch; Sara B DeMauro; Justine Shults; Samuel R Pierce; Elizabeth Ballance; Tracy Kornafel; Ann Harrington; Allan M Glanzman; Adeline Vanderver Journal: Pediatr Neurol Date: 2021-09-24 Impact factor: 4.210
Authors: Brian E Bunnell; Nikolaos Kazantzis; Samantha R Paige; Janelle Barrera; Rajvi N Thakkar; Dylan Turner; Brandon M Welch Journal: Front Psychol Date: 2021-05-07
Authors: Evelien De Sutter; Drieda Zaçe; Stefania Boccia; Maria Luisa Di Pietro; David Geerts; Pascal Borry; Isabelle Huys Journal: J Med Internet Res Date: 2020-10-08 Impact factor: 5.428
Authors: Brian E Bunnell; Janelle F Barrera; Samantha R Paige; Dylan Turner; Brandon M Welch Journal: Int J Environ Res Public Health Date: 2020-11-17 Impact factor: 3.390
Authors: Emily Skelton; Nicholas Drey; Mary Rutherford; Susan Ayers; Christina Malamateniou Journal: Int J Med Inform Date: 2020-09-13 Impact factor: 4.046